Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
3 Hidden Healthcare Stocks Poised for a Breakout This Year
January 30, 2024
Tickers
MCK
NVS
Tags
TDOC/NYSE
NYSE:MCK,NYSE:NVS,NYSE:TDOC/NYSE:GSK
NVS
From
InvestorPlace
Earnings Outlook For Novartis
January 30, 2024
Tickers
NVS
Tags
Benzinga
NVS
Earnings
From
Benzinga
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
Tickers
AAPL
ABBV
AMD
AMZN
Tags
NVS
SNY
AMZN
From
Benzinga
Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of "Risks Of Secondary Cancer'
January 24, 2024
Tickers
BMY
GILD
JNJ
NEWS
Tags
Health Care
BMY
Large Cap
From
Benzinga
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
January 23, 2024
Tickers
AZN
BMY
GILD
GRCL
Tags
NVS
News
Briefs
From
Benzinga
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
January 12, 2024
Tickers
AZN
BMY
CYTK
NEWS
Tags
Analyst Color
Expert Ideas
Reiteration
From
Benzinga
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
January 11, 2024
Tickers
CYTK
NEWS
NVS
Tags
Movers
NVS
Briefs
From
Benzinga
What's Been Happening With Cytokinetics Stock?
January 09, 2024
Tickers
CYTK
NEWS
NVS
Tags
News
why it's moving
Movers
From
Benzinga
Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today?
January 08, 2024
Tickers
CYTK
NEWS
NVS
Tags
Biotech
Large Cap
Eurasia
From
Benzinga
Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?
January 08, 2024
Tickers
EXEL
MRK
NEWS
NVS
Tags
Health Care
Equities
Biotech
From
Benzinga
Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery
January 08, 2024
Tickers
GOOG
GOOGL
LLY
NEWS
Tags
Briefs
News
NVS
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
January 05, 2024
Tickers
NVS
Tags
NVS
Market News
BZI/SHORTHIST
From
Benzinga
Voyager Therapeutics Stock Tanked After-Hours - Here's Why
January 04, 2024
Tickers
NEWS
NVS
VYGR
Tags
VYGR
Small Cap
why it's moving
From
Benzinga
Big Players' Recent Trades in NVS Options
January 04, 2024
Tickers
NVS
Tags
NVS
Market News
BZI/UOA
From
Benzinga
VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today
January 02, 2024
Tickers
AZN
NBIX
NVS
VYGR
Tags
NBIX
AZN
Today's Market
From
InvestorPlace
Why Is Gene Therapy Focused Voyager Therapeutics Stock Soaring Today?
January 02, 2024
Tickers
NEWS
NVS
VYGR
Tags
News
why it's moving
Briefs
From
Benzinga
Why Is Neurology Focused Cingulate Stock Trading Higher Today?
December 28, 2023
Tickers
CING
NEWS
NVS
Tags
CING
Biotech
Health Care
From
Benzinga
Why Is Cytokinetics (CYTK) Stock Up 70% Today?
December 27, 2023
Tickers
AZN
BMY
CYTK
NVS
Tags
CYTK
Market News
BMY
From
InvestorPlace
These 3 Big Pharma Stocks Are Making Big Plays With AI
December 22, 2023
Tickers
AZN
LLY
NVS
Tags
LLY
Recent Press Releases
Market News
From
Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Tickers
CALT
MCK
NVS
RHHBY
Tags
RHHBY
General
VERA
From
Benzinga
Fusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside
December 20, 2023
Tickers
AZN
FUSN
NVS
Tags
Initiation
Analyst Color
Expert Ideas
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 20, 2023
Tickers
NVS
Tags
Benzinga
Trading Ideas
Short Sellers
From
Benzinga
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
December 19, 2023
Tickers
LNTH
NVS
PNT
Tags
Health Care
Biotech
Small Cap
From
Benzinga
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
December 17, 2023
Tickers
ECX
FSR
FTRE
GELYF
Tags
STLA
GELYF
MZDAY
From
InvestorPlace
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Tickers
MRK
NVS
Tags
FDA
Benzinga
Market News
From
Benzinga
Novartis' Newly FDA-Approved Rare Blood Disorder Drug Aces Phase 3 Study In Ultra Rare Kidney Failure Disease
December 11, 2023
Tickers
NVS
Tags
Biotech
Large Cap
Eurasia
From
Benzinga
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
December 10, 2023
Tickers
BMY
GILD
NVS
Tags
GILD
Market News
NVS
From
Motley Fool
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Tickers
NVS
Tags
FDA
Benzinga
Market News
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 01, 2023
Tickers
NVS
Tags
BZI/SHORTHIST
Short Ideas
Market News
From
Benzinga
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
Tickers
BMY
GILD
JNJ
NVS
Tags
Market News
GILD
FDA
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.